Patient Information - North America
 
  

Through the provision of guides which detail the Radiation Therapy, Gamma Knife® Surgery treatment processes and MEG Patient Examination, we aim to answer the most frequently asked questions by patients and their families.

We also offer an extensive list of patient organizations and healthcare resources which offer valueable support before, during and after treatment. Additional resources include a comprehensive section on some of the key cancer types covering diagnosis, risk factor, treatment alternatives, follow-up care and patient stories provided by clinical partners.


KEY CANCER TYPES:

Select condition below:

Bladder Cancer
Brain Tumors
Breast Cancer
Colo-rectal Cancer
Hodgkins Lymphoma
Non-Hodgkins Lymphoma
Kidney Cancer
Liver Cancer
Lung Cancer
Pancreatic Cancer
Prostate Cancer


ELEKTA TREATMENT CENTERS

LEKSELL GAMMA KNIFE® CENTERS:

North America

     Meg_pat_banner.jpg

ELEKTA NEUROMAG® CENTERS:

Worldwide




Note: This website is not intended as a substitute for professional medical advice and does not provide advice on treatments or conditions for individual patients. All health and treatment decisions must be made in consultation with your physician(s), utilizing your specific medical information.

The links set out on this web site are provided for your convenience only. Elekta does not endorse the information contained on the linked web sites or individual(s) / companies / institutions operating these web site(s).


Pallidotomy: A Medical Miracle for Parkinson’s Disease?


A non-invasive alternative for many patients for whom traditional brain surgery is not an option

Of all the brain scanning methods, MEG provides the most accurate resolution of the timing of nerve cell activity

IMRT will allow our physicians to deliver substantially more cancer-killing energy to tumors

Tumors that were previously untreatable, because of their proximity to organs or the spinal cord, can now receive treatment

The low volume of lung exposed to radiation allows very high doses to be given to the lung tumor leading to cure rates comparable to surgery

  Sitemap  
 © Copyright 2008 Elekta AB (publ). All rights reserved.